SarahStar Posted - 8 hours ago

MYNZ I don't give a damn about bots, I trust this stock 100000000%. Deal with Thermo Fisher Healthcare Giant is a huge credibility. 1/ German gov stake 10% 2/ Thermo Fisher partnership 3/ Frankie Muniz Malcolm in the Middle support 4/ Petra Starke former WH senior advisor of Obama 5/ 75M patients coverage in EU + 9labs 6/ 88% pre-cancer results unlike competitors EXAS 43% and GH 13%. 7/ RS will be cancelled 🤞extension of 180 days by nasdaq? 8/ 30M shares offering deal, TMO will get that? Wtf are you waiting for ??? Crush this shorties 🔥🚀 $PHVS $PRAX

JordanBall Posted - 1 day ago

$PHVS $PRAX LFG, expected this to move higher. Also, your thoughts on MYNZ? Who's behind the 30M share offering deal? 👀 And how could the Thermo Fisher (TMO) partnership ($210B market cap) reflect this stock movement and PR buzz everywhere on socials?

Andrea_Stephens Posted - 2 days ago

MYNZ: Who’s Next After TMO? 🚀 🔥 LabConnect: Central lab for clinical trials—big potential clients. 🌍 Genova Diagnostics: 50+ countries, serving healthcare pros globally. 🔬 ACM Global: Central lab player for clinical trials—big reach. 🏥 ARUP: Trusted by U.S. hospitals and clinics nationwide. 🩺 Mayo Clinic Labs: Partners with 4,000+ global healthcare orgs. 💡 Quest Diagnostics: Serves ~50% of U.S. hospitals & doctors. 🌐 Labcorp: Massive global network in 100+ countries. 🔗 OPKO/BioReference: Multinational lab powerhouse. 📊 Sonic Healthcare: Global diagnostics + radiology leader. ⚡ BioReference: 12M+ tests/year across U.S. facilities. 🚀 TMO is already on board ($210B market cap)—who’s next? LET’S GOOO! 💥 $PHVS $PRAX $INVA

AnalRetort Posted - 6 days ago

$PRAX damn bro general counsel dumping half his shares in an unplanned sale prior to readout. 600k. Lots of hopes on a solid readout but I see delays.

justiceforb_85 Posted - 6 days ago

$PRAX took a position here. With positive data for relutrigine in rare encephalopathies and upcoming read-out for ulixacaltamide (hopefully the adjusted primary endpoint is met), this will go up.

Quantumup Posted - 1 week ago

Piper Sandler reit'd $PRAX OW/$270, after⬆️beat🗣️w/ MGMT Re ulixacaltamide's ET opp (details in🖼️). Following its🗣️PS said, "we continue to believe PRAX is one of our best ideas of 2025 with ET representing a significant opportunity in addition to PRAX's robust epilepsy program.

ChartLaboratory_com Posted - 1 week ago

$RDNT 📊 Price: $86.38 Up 19.10% Key Resistance: $93.65 Potential Target: $93.65 Strong momentum. Watch for a breakout to the upside 💥 For more insights and strategies, check out www.patreon.com/chartlab 📈 $HUT ⛏️ Price: $24.59 Up 25.56% Key Support: $20.57 Potential Target: $25.32 Bullish trend, look for continuation above $25.00 🚀 Get actionable trade plans and alerts: www.patreon.com/chartlab 🔥 $INOD 📈 Price: $45.90 Up 7.29% Resistance at $47.81 Target: $47.81 Price trending higher, keep an eye on the breakout 📊 For more details, follow: www.patreon.com/chartlab 🚀 $CRSP 🧬 Price: $54.86 Up 6.28% Key Support: $53.00 Target: $59.07 Potential continuation upwards, keep an eye on this setup! 📈 For more updates, visit www.patreon.com/chartlab 📊 $PRAX 🚀 Price: $84.83 Up 8.93% Resistance at $86.81 Target: $86.81 Strong momentum; watch for further bullish movement 📉 Follow for more insights at www.patreon.com/chartlab 📈

ChartLaboratory_com Posted - 1 week ago

$RDNT 📊 Price: $86.38 Up 19.10% Key Resistance: $93.65 Potential Target: $93.65 Strong momentum. Watch for a breakout to the upside 💥 For more insights and strategies, check out www.patreon.com/chartlab 📈 $HUT ⛏️ Price: $24.59 Up 25.56% Key Support: $20.57 Potential Target: $25.32 Bullish trend, look for continuation above $25.00 🚀 Get actionable trade plans and alerts: www.patreon.com/chartlab 🔥 $INOD 📈 Price: $45.90 Up 7.29% Resistance at $47.81 Target: $47.81 Price trending higher, keep an eye on the breakout 📊 For more details, follow: www.patreon.com/chartlab 🚀 $CRSP 🧬 Price: $54.86 Up 6.28% Key Support: $53.00 Target: $59.07 Potential continuation upwards, keep an eye on this setup! 📈 For more updates, visit www.patreon.com/chartlab 📊 $PRAX 🚀 Price: $84.83 Up 8.93% Resistance at $86.81 Target: $86.81 Strong momentum; watch for further bullish movement 📉 Follow for more insights at www.patreon.com/chartlab 📈

King_S Posted - 2 weeks ago

MYNZ moving +12.25% in PM and opening climbing up same with volume 🚀 All is buying, ready for the squeeze. HUGE PR drop incoming before the Nov 13 meeting, so compliance is coming, no RS needed. $PHVS $PRAX $INVA

Quantumup Posted - 2 weeks ago

Guggenheim reiterated $PRAX Buy/$170, after 3Q24📰 NDA filing guidance for '25 remains on🛤️—interim look gives PRAX an optionality to adj sample size/⬆️POS—Gugg🩷R/R; thinks the stock could move 2-3x/-30% on ET data—MGMT seem confident in the success of this program+plans2 re🏁PD study:

VrtcIl Posted - 2 weeks ago

What are your targets on $PRAX? Closest round level at 73. Take out profits right before those round numbers. Many orders on those levels are waiting to get filled. Price: 72.66 Float: 116.6M Short Float: 10.5 % 💰 Dollar Volume: 156.8K ℹ️ USA | Biotechnology

VrtcIl Posted - 2 weeks ago

Do not FOMO in $PRAX now. Consider waiting for consolidations and aim for entry points with a tighter stop to manage risk effectively based on the technical chart setup. Price: 69.35 Float: 116.6M Short Float: 10.5 % 💰 Dollar Volume: 192.2K ℹ️ USA | Biotechnology

HaltTradeAlert Posted - 2 weeks ago

$PRAX Halt Time: 09:33:01 Issue Symbol: PRAX Reason Code: LUDP Last Price: $0 Volume: 42.8 K Members get this halt alert with no delay and with more info: shares outstanding, market cap, relative volume, and percentage change on the day. Also, halt alerts for pre-market hours and after market hours which is extremely important for Code T1 News Pending Alerts!! And free real time news catalyst alerts!

AivelX Posted - 2 weeks ago

💡 #AivelX Tomorrow Premarket Earnings Insights (1/2) 🧵 Earnings breakdown for: $CVS, $LNTH, $NVO, $PRAX CVS - Ref.Earnings: 32 Gap Up Prob.: 41%, max 2.4%, min -17.4%, avg -2.2% Avg Low vs Open: -6.2% Avg Close vs Low: 6.2% Avg Low-High %: 12% 5 Days Later: 44% new highs, 72% new lows Earnings Day: 19% broke 56.5 (+2.7%) LNTH - Ref.Earnings: 1230 Gap Up Prob.: 69%, max 9.5%, min -14.5%, avg 0.6% Avg Low vs Open: -1.3% Avg Close vs Low: 2.1% Avg Low-High %: 3.5% 5 Days Later: 53% new highs, 73% new lows Earnings Day: 13% broke 108 (-3.9%) NVO - Ref.Earnings: 146 Gap Up Prob.: 45%, max 9.2%, min -17.9%, avg -1.7% Avg Low vs Open: -4.5% Avg Close vs Low: 2.8% Avg Low-High %: 7.2% 5 Days Later: 43% new highs, 70% new lows Earnings Day: 32% broke 112.3 (+2.8%) PRAX - Ref.Earnings: 27 Gap Up Prob.: 93%, max 14%, min -2.2%, avg 2.6% Avg Low vs Open: -2.1% Avg Close vs Low: 5% Avg Low-High %: 7.8% 5 Days Later: 81% new highs, 52% new lows Earnings Day: 41% broke 70.4 (-1.4%)

G101SPM Posted - 2 weeks ago

$PRAX $71.40 bid. SELL/TAKE PROFIT on 20% position. EXIT $95.00 as Legacy Holding (currently holding a 30% position) * DAC (dollar average cost includes prior sales of 70% to reduce original cost to $11.25). note: Original purchase was at $1.55 (9.19.23) subject to 1:15 reverse split ($23.25). * Click SEARCH (magnifying glass) icon on our landing page to review the postings.

MaverikIT Posted - 2 weeks ago

@net0trader @RonIsWrong $PRAX +3.30

IN0V8 Posted - 10/31/24

$PRAX Opportunity Oppenheimer raises target to $163 from $143

G101SPM Posted - 10/25/24

$PRAX $72.00 bid. DAC (dollar average cost includes profit taking on partial position to reduce cost to $15.25). CHANGE EXIT TO $125.00 FROM $95.00 - Legacy Holding. OVERVIEW: Praxis Precision Medicines, Inc. is a promising clinical-stage biopharmaceutical company focused on developing innovative therapies for central nervous system (CNS) disorders, particularly those stemming from an imbalance between neuronal excitation and inhibition; on track to conduct an interim analysis for its Essential3 study in Q4 2024, with topline results expected later this year, potentially paving the way for a New Drug Application (NDA) filing in 2025. Additionally, the company is advancing PRAX-562 for pediatric patients with developmental and epileptic encephalopathies (DEE), with topline results from the Phase 2 EMBOLD study anticipated in Q3 2024. note: Number of Hedge Fund Holders: 28

WAS111 Posted - 10/25/24

$SDOT This CEO Mr. Roper is shameless, morally corrupt, and has no respect for shareholders. I have never seen a more stupid and foolish CEO than Mr. Roper in my life. A market cap of $13.7m for a company with revenues of $725m. What stupidity is this? A company like $PRAX loses over $10 per share and jumps 330% to a market cap of $1.27 billion and $SDOT makes $0.50 per quarter and trades at a market cap of $13.7m. I always say that Mr. Roper should be fired or go to hell, he is not worthy of the trust that has been placed in him by the shareholders. I could buy another 100k but with that idiot Mr. Roper as CEO I won't add any more because his actions show that there is something wrong with his mind.!!

MaverikIT Posted - 10/24/24

@IsabellaDC @net0trader $VKTX $PRAX $BHVN

MaverikIT Posted - 1 month ago

@IsabellaDC @net0trader $PRAX

AnalRetort Posted - 1 month ago

$PRAX the CEO and board just setup their golden parachutes 😂

swingingtech Posted - 1 month ago

$MDB $PRAX $CR https://wallstreetwaves.com/highlighting-significant-monday-options-trading-mdb-prax-cr/

kshonstocks Posted - 1 month ago

$PRAX pretty

Doozio Posted - 1 month ago

$PRAX 🧠⏰♾️

MaverikIT Posted - 1 month ago

@IsabellaDC @net0trader @RonIsWrong $SRRK $PRAX $IESC

justiceforb_85 Posted - 1 month ago

$PRAX do we have an idea of when phase 3 results for ulixacaltamide will be released?

Fugazi_ Posted - 1 month ago

$PRAX a lot of sold calls and bought puts stay safe

tradingmindsetanddata Posted - 1 month ago

$PRAX Under our scanner as accumulation signal has been triggered, very strong OTM call buying C90 November term. Probably news coming out, this is a biotech company.

OptionRunners Posted - 1 month ago

$PRAX +11% today with the February $65 calls now ITM. The risk reversals are now trading about $20.00 and are still in the OI. And more bullish flow this morning with a buyer of the November $65/$90 call spreads 1,500 times for $8.40